PDCD1 and hypothyroidism: In addition, presentations of hypothyroidism, hyperthyroidism and pneumonitis due to PD-1/PD-L1 antibodies are 23.36, 5.10 and 3.19 folds higher than docetaxel group (P < 0.001).